Identification of Basic Residues in the Heparin-binding Exosite of Factor Xa Critical for Heparin and Factor Va Binding*

We recently demonstrated that a template mechanism makes a significant contribution to the heparin-accelerated inactivation of factor Xa (FXa) by antithrombin at physiologic Ca2+, suggesting that FXa has a potential heparin-binding site. Structural data indicate that 7 of the 11 basic residues of the heparin-binding exosite of thrombin are conserved at similar three-dimensional locations in FXa. These residues, Arg93, Lys96, Arg125, Arg165, Lys169, Lys236, and Arg240 were substituted with Ala in separate constructs in Gla domainless forms. It was found that all derivatives cleave Spectrozyme FXa with similar catalytic efficiencies. Antithrombin inactivated FXa derivatives with a similar second-order association rate constant (k 2) in both the absence and presence of pentasaccharide. In the presence of heparin, however,k 2 with certain mutants were impaired up to 25-fold. Moreover, these mutants bound to heparin-Sepharose with lower affinities. Heparin concentration dependence of the inactivation revealed that only the template portion of the cofactor effect of heparin was affected by the mutagenesis. The order of importance of these residues for binding heparin was as follows: Arg240> Lys236 > Lys169 > Arg165 > Lys96 > Arg93 ≥ Arg125. Interestingly, further study suggested that certain basic residues of this site, particularly Arg165 and Lys169, play key roles in factor Va and/or prothrombin recognition by FXa in prothrombinase.

[1]  S. Bajaj,et al.  Protease and EGF1 Domains of Factor IXa Play Distinct Roles in Binding to Factor VIIIa , 1999, The Journal of Biological Chemistry.

[2]  K. R. Dharmawardana,et al.  Demonstration of exosite I-dependent interactions of thrombin with human factor V and factor Va involving the factor Va heavy chain: analysis by affinity chromatography employing a novel method for active-site-selective immobilization of serine proteinases. , 1998, Biochemistry.

[3]  A. Rezaie Calcium Enhances Heparin Catalysis of the Antithrombin-Factor Xa Reaction by a Template Mechanism , 1998, The Journal of Biological Chemistry.

[4]  A. Betz,et al.  Regions Remote from the Site of Cleavage Determine Macromolecular Substrate Recognition by the Prothrombinase Complex* , 1998, The Journal of Biological Chemistry.

[5]  A. Betz,et al.  Exosites determine macromolecular substrate recognition by prothrombinase. , 1997, Biochemistry.

[6]  C. Esmon,et al.  Influence of Arginines 93, 97, and 101 of thrombin to its functional specificity. , 1997, Biochemistry.

[7]  A. Rezaie Role of Residue 99 at the S2 Subsite of Factor Xa and Activated Protein C in Enzyme Specificity* , 1996, The Journal of Biological Chemistry.

[8]  C. Esmon,et al.  Involvement of Thrombin Anion-binding Exosites 1 and 2 in the Activation of Factor V and Factor VIII* , 1996, The Journal of Biological Chemistry.

[9]  A. Rezaie Tryptophan 60-D in the B-insertion loop of thrombin modulates the thrombin-antithrombin reaction. , 1996, Biochemistry.

[10]  C. Esmon,et al.  Contribution of Residue 192 in Factor Xa to Enzyme Specificity and Function (*) , 1995, The Journal of Biological Chemistry.

[11]  S. Olson,et al.  Mechanism of Acceleration of Antithrombin-Proteinase Reactions by Low Affinity Heparin , 1995, The Journal of Biological Chemistry.

[12]  C. Esmon,et al.  Asp-70-->Lys mutant of factor X lacks high affinity Ca2+ binding site yet retains function. , 1994, Journal of Biological Chemistry.

[13]  C. Esmon,et al.  Glycosaminoglycan contributions to both protein C activation and thrombin inhibition involve a common arginine-rich site in thrombin that includes residues arginine 93, 97, and 101. , 1994, The Journal of biological chemistry.

[14]  J. Sheehan,et al.  Molecular mapping of the heparin-binding exosite of thrombin. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Y. Li,et al.  Identification of basic amino acid residues in thrombin essential for heparin-catalyzed inactivation by antithrombin III. , 1994, The Journal of biological chemistry.

[16]  R. Huber,et al.  Structure of human des(1-45) factor Xa at 2.2 A resolution. , 1993, Journal of molecular biology.

[17]  C. Esmon,et al.  Analysis of the functions of the first epidermal growth factor-like domain of factor X. , 1993, The Journal of biological chemistry.

[18]  C. Esmon,et al.  The function of calcium in protein C activation by thrombin and the thrombin-thrombomodulin complex can be distinguished by mutational analysis of protein C derivatives. , 1992, The Journal of biological chemistry.

[19]  R. Carrell,et al.  Heparin binding site, conformational change, and activation of antithrombin. , 1992, Biochemistry.

[20]  S. Olson,et al.  Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement. , 1992, The Journal of biological chemistry.

[21]  H. James,et al.  Molecular recognition sites on factor Xa which participate in the prothrombinase complex. , 1992, The Journal of biological chemistry.

[22]  S. Thein,et al.  Antithrombin and its deficiency states. , 1992, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[23]  H. Halvorson,et al.  Quantitative characterization of the thrombin-heparin interaction. Discrimination between specific and nonspecific binding models. , 1991, The Journal of biological chemistry.

[24]  J. Stenflo,et al.  The gamma-carboxyglutamic acid and epidermal growth factor-like domains of factor X. Effect of isolated domains on prothrombin activation and endothelial cell binding of factor X. , 1991, Journal of Biological Chemistry.

[25]  B. Owen,et al.  Interaction of factor Xa with heparin does not contribute to the inhibition of factor Xa by antithrombin III-heparin. , 1990, Biochemistry.

[26]  Kenneth G. Mann,et al.  Surface-dependent reactions of the vitamin K-dependent enzyme complexes , 1990 .

[27]  A. Giles,et al.  Studies of the role of factor Va in the factor Xa-catalyzed activation of prothrombin, fragment 1.2-prethrombin-2, and dansyl-L-glutamyl-glycyl-L-arginine-meizothrombin in the absence of phospholipid. , 1990, The Journal of biological chemistry.

[28]  R. Huber,et al.  The refined 1.9 A crystal structure of human alpha‐thrombin: interaction with D‐Phe‐Pro‐Arg chloromethylketone and significance of the Tyr‐Pro‐Pro‐Trp insertion segment. , 1989, The EMBO journal.

[29]  H. Hemker,et al.  Antithrombin III-dependent anti-prothrombinase activity of heparin and heparin fragments. , 1989, The Journal of biological chemistry.

[30]  S. Olson,et al.  Transient kinetics of heparin-catalyzed protease inactivation by antithrombin III. Characterization of assembly, product formation, and heparin dissociation steps in the factor Xa reaction. , 1989, The Journal of biological chemistry.

[31]  C. Esmon,et al.  The active site of blood coagulation factor Xa. Its distance from the phospholipid surface and its conformational sensitivity to components of the prothrombinase complex. , 1987, The Journal of biological chemistry.

[32]  Å. Danielsson,et al.  Role of ternary complexes, in which heparin binds both antithrombin and proteinase, in the acceleration of the reactions between antithrombin and thrombin or factor Xa. , 1986, The Journal of biological chemistry.

[33]  K. Kurachi,et al.  Gene for human factor X: a blood coagulation factor whose gene organization is essentially identical with that of factor IX and protein C. , 1986, Biochemistry.

[34]  M. Scully,et al.  The relative molecular mass dependence of the anti-factor Xa properties of heparin. , 1986, The Biochemical journal.

[35]  C. Esmon,et al.  Comparison of coagulation factor Xa and des-(1-44)factor Xa in the assembly of prothrombinase. , 1984, The Journal of biological chemistry.

[36]  M. Griffith Measurement of the heparin enhanced-antithrombin III/thrombin reaction rate in the presence of synthetic substrate. , 1982, Thrombosis research.

[37]  G M Oosta,et al.  The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin. , 1980, The Journal of biological chemistry.

[38]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[39]  R. Rosenberg,et al.  Anticoagulant Action of Heparin , 1973, Nature.

[40]  S. Olson,et al.  Regulation of Thrombin by Antithrombin and Heparin Cofactor II , 1992 .

[41]  K. Mann,et al.  Cofactor proteins in the assembly and expression of blood clotting enzyme complexes. , 1988, Annual review of biochemistry.

[42]  M. Scully,et al.  The acceleration of the inhibition of platelet prothrombinase complex by heparin. , 1986, The Biochemical journal.